US CDC warns of uptick in meningitis in kids

Fri Jan 23, 2009 7:12pm GMT

[-] Text [+]

WASHINGTON, Jan 23 (Reuters) - A rise in illnesses caused by a bacterial infection among children in Minnesota, including a fatal case of meningitis, may stem from a shortage of vaccine for the HiB bacteria, U.S. health officials said on Friday.

The U.S. Centers for Disease Control and Prevention said the situation in Minnesota, where five children became gravely ill from HiB, may indicate that the bacteria is threatening more children because many have not received booster doses.

Authorities are particularly concerned about bacterial meningitis caused by HiB (Haemophilus influenzae type B) in children. Meningitis is the inflammation of the tissue surrounding the brain and spinal cord, and can be caused by viral or bacterial infections.

Five children became ill last year with meningitis, pneumonia and other HiB-caused diseases in Minnesota, and a 7-year-old child died of meningitis, the CDC said. It was the highest number of HiB illnesses in the state since 1992. In 2006, there was only one case.

"We believe that exposure to the HiB bacteria has increased in Minnesota, and children -- mainly those who are unvaccinated -- are at higher risk that they used to be," Dr. Anne Schuchat, director of the CDC's National Center for Immunization and Respiratory Diseases, said in a telephone interview.

The child who died had not received any vaccination because of the parents' personal beliefs, health officials said.

Merck & Co Inc (MRK.N: Quote, Profile, Research) in 2007 recalled its HiB vaccines because production equipment may not have been properly sterilized. Merck initially said the PedvaxHIB and COMVAX vaccines would return to the U.S. market late this year, but in October said they would not do so until mid-2009.

HiB vaccine made by Sanofi Pasteur, the vaccines division of Sanofi-Aventis (SASY.PA: Quote, Profile, Research), remains available. But because of the absence of the Merck vaccines, the CDC has asked doctors to postpone the routine HiB vaccine booster doses typically given at age 12- to 15 months until the vaccine supply improves. Continued...